Search results
Found 1083 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
$2m fund awarded for Oxford’s single-cell ancestry vaccine research
General Research
17 November 2021
The University of Oxford is to benefit from $2 million (£1.49 million) in funding from the Chan Zuckerberg Initiative (CZI) to investigate how our ancestry and diversity influence the way that vaccines work in our cells.
New research reveals link between ankle pain and onset of knee osteoarthritis
General Research
16 November 2021
A new study published in Osteoarthritis and Cartilage Open could help improve the lives of people at risk of developing knee osteoarthritis.
Global antibiotic consumption rates increased by 46 percent since 2000
General Research
16 November 2021
Antibiotic consumption rates grew by 46 percent after 2000, according to findings which also suggest lack of treatment access in some areas.
Oxford vaccine reaches two billion dose milestone
Coronavirus COVID-19 General Research
16 November 2021
Researchers explain how unprecedented manufacturing strategy provides a template for future global vaccine supply.
Arm and shoulder disability and pain after breast cancer surgery reduced by exercise
General Research
15 November 2021
The debilitating arm and shoulder disability and pain that some women who have had breast cancer surgery experience as a side effect of their surgery can be reduced by following a physiotherapy-led exercise programme after their operation, a new study has found.
Chan Zuckerberg Initiative funding awarded to build a globally inclusive musculoskeletal map
General Research
12 November 2021
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) researchers and several international collaborators have been awarded funding from the Chan Zuckerberg Initiative to deliver an ancestrally diverse musculoskeletal atlas of healthy tissues.
Ebola vaccine to begin human trials
Clinical Trials General Research
11 November 2021
The University of Oxford have begun recruiting for a Phase I trial to test an Ebola vaccine in human volunteers – with the first vaccinations having already taken place.
New advanced analytics research to deliver next level of insights into COVID-19
Coronavirus COVID-19 General Research
11 November 2021
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) is leading one of nine new studies awarded total of £2m to use large-scale linked data to address priority research questions that will improve understanding of the pandemic and inform the continued policy response.
Sustainable eating is cheaper and healthier - Oxford study
General Research
11 November 2021
Global study shows vegan and vegetarian diets cheapest option in high-income countries ‘£1 Chef’ Miguel Barclay backs study
Researchers uncover gene that doubles risk of death from COVID-19
Coronavirus COVID-19 General Research
8 November 2021
Scientists at Oxford University have identified the gene responsible for doubling the risk of respiratory failure from COVID-19. Sixty percent of people with South Asian ancestry carry the high-risk genetic signal, partly explaining the excess deaths seen in some UK communities, and the impact of COVID-19 in the Indian subcontinent.
Large-scale genetic study reveals new clues for the shared origins of irritable bowel syndrome and mental health disorders
General Research
5 November 2021
An international study of more than 50,000 people with irritable bowel syndrome (IBS) has revealed that IBS symptoms may be caused by the same biological processes as conditions such as anxiety. The research highlights the close relationship between brain and gut health and paves the way for development of new treatments.
Oxford joins consortium to advance quantum drug discovery with £6.8M grant from Innovate UK
General Innovation Research
5 November 2021
Oxford University today joins a consortium led by the digital quantum computing company, SEEQC, to build and deliver a full-stack quantum computer for pharmaceutical drug development for Merck KGaA.
New European initiative to accelerate the discovery and validation of biomarkers for neurodegenerative diseases
General Research
3 November 2021
Members of the European Platform for Neurodegenerative Diseases (EPND) will establish a collaborative platform for efficient sample and data sharing, linking existing European research infrastructures to accelerate the discovery of biomarkers, new diagnostics and treatments for the benefit of people with neurodegenerative diseases such as Alzheimer's and Parkinson's.
Oxford to work with Brazil to establish clinical research hub
General Research
2 November 2021
The University of Oxford and Brazilian Ministry of Health have announced a joint initiative to set up a global health and clinical research unit in Brazil led by Professor Sue Ann Clemens CBE.
PTSD in healthcare workers during pandemic could be exacerbated by past trauma
Coronavirus COVID-19 General Research
29 October 2021
While some of the high rates of post-traumatic stress (PTSD) seen in healthcare workers during the pandemic are specifically COVID-19-related, a more significant number of cases were linked to trauma that occurred earlier in their lives, researchers at the University of Oxford have found.
Oxford researchers test potential treatment for fatigue in long COVID patients
Clinical Trials Coronavirus COVID-19 General Research
29 October 2021
Radcliffe Department of Medicine researcher Dr Betty Raman is leading a new phase 2a clinical trial to investigate whether a drug could treat the fatigue and muscle weakness experienced by many patients who have recovered from COVID. The drug, AXA1125, is developed by the US-based biotechnology company Axcella Therapeutics.
Major new research network to investigate the body clock and stroke
General Research
29 October 2021
The University of Oxford is part of a new international research network to investigate the interactions between the biology of the body’s internal clock and the disordered physiological processes associated with stroke.
Wearing face coverings protected wearers from COVID-19 infection – large scale study
Coronavirus COVID-19 General Research
28 October 2021
People who wore face coverings or masks outside of the home, and were more exposed to infection due to their circumstances, had ‘significantly’ lower rates of COVID-19 infection, according to research published in BMJ Open today, led by Oxford’s Leverhulme Centre for Demographic Science.
Oxford-led team given £6.6m to map uncharted networks in the progression of Parkinson’s
General Research
26 October 2021
A major new $9 million (£6.6 million) project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. It is the only UK-led ASAP project this year, and the first ever to be led by Oxford.